Balconsp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2002-05-07
Share capital
50 000,00 PLN
Registered address
Samarytanka 19A, 03-592 Warszawa, Poland
Financials
1 of the last 5 financial statements were filed late.
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 41.70kMedianUSD 561.73kAverageUSD 765.08k
Net profit
This companyUSD 749.29MedianUSD 21.77kAverageUSD 30.89k
Operating costs
This companyUSD 40.81kMedianUSD 512.92kAverageUSD 724.16k
Assets
This companyUSD 43.58kMedianUSD 419.73kAverageUSD 559.39k
Industry
- Publishing activities (22.1)
- Printing (22.2)
Bank accounts
Registered as a VAT taxpayer on 1994-11-23.
02 1020 1013 0000 0402 0127 5023
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Authorized Representatives
Bogusława Bożena Kańczuga – Management Board Member
Waldemar Kańczuga – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bogusława Bożena Kańczuga (70) | 50 | $6,753.11 | 50% |
Waldemar Kańczuga (70) | 50 | $6,753.11 | 50% |
Bogusława Bożena Kańczuga and Waldemar Kańczuga hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
FAQ
The company was registered in the Polish National Court Register (KRS) on May 7, 2002.
The headquarters is located at: Samarytanka 19A, 03-592 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $41,700 in 2025, which is an increase of 7.1% compared to 2024.
Yes, the company recorded a net profit of $749 in 2025, meaning the company decreased its profit by 61.1%.
The largest operating cost category falls under employee remuneration. This category amounted to $26,067 in 2025, representing 64% of all operating expenses.
Last updated: 2026-05-05